VetSheet

Pyriprole

Antiparasitic - PhenylpyrazoleTopicalDogsCats

Also known as: Prac-tic

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

minimum dose 12.5 mg/kgtopicalΒ· q4wk
β€” πŸ•

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA β€” North America🌍 EU β€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Fleas and ticksminimum dose 12.5 mg/kgtopicalq4wkβ€”πŸŒ EU
  • Fleas and ticks: For large dogs, the 5 ml dose should be applied in 2-3 spots.

Cats

IndicationDoseRouteFrequencyDurationRegion
ContraindicatedDo not use.topicalβ€”β€”πŸŒ EU
  • Contraindicated: Strictly contraindicated in cats.

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Pyriprole is a phenylpyrazole antiparasitic agent used for the treatment and prevention of flea infestations (Ctenocephalides canis, C. felis) and tick prevention in dogs. It is applied topically as a spot-on solution.

​Clinical Warning:​ Do not use on cats. Safety has not been established in pregnant and lactating females, or in dogs under 8 weeks of age or weighing less than 2 kg.

Mechanism of action

Pyriprole acts by interacting with ligand-gated (GABA) chloride channels, blocking the pre- and post-synaptic transfer of chloride ions β†’ leading to hyperexcitation of the central nervous system and subsequent death of the parasites.

Safety & warnings

Contraindications

  • Cats
  • Pregnant and lactating females (safety not established)
  • Dogs < 8 weeks of age
  • Dogs < 2 kg body weight

Adverse effects

  • Pruritus/dermatitis at application site
  • Lethargy
  • Ataxia
  • Convulsions
  • Emesis
  • Diarrhoea

Precautions

​Do not use on cats.​ Bathing is not recommended for 48 hours prior to and 24 hours after application. May be harmful to aquatic organisms; prevent access to watercourses. For large dogs, the 5 ml dose should be applied in 2-3 spots. For treatment of flea infestations, the additional use of an approved insect growth regulator is recommended.

Monitoring

  • Efficacy of flea and tick control
  • Application site reactions
  • Neurological signs (ataxia, convulsions)

Overdose

No specific information available in the monograph. Overdose may exacerbate known adverse reactions such as neurological signs (ataxia, convulsions) and gastrointestinal upset (emesis, diarrhoea). Treat symptomatically.

Available products

Formulations

  • Topical: 125 mg/ml spot-on pipettes of various sizes

Veterinary

  • Prac-tic 125 mg/ml spot-on pipettes

Regulatory status

European Unionβœ“ ApprovedPrescription onlyEMA
πŸ• Dogs

POM-V

United Kingdomβœ“ ApprovedPrescription onlyVMD
πŸ• Dogs

POM-V

No regulatory data for: πŸ‡ΊπŸ‡Έ US Β· πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

Normal precautions should be observed.

Client information

Apply the spot-on solution directly to your dog's skin as directed. For large dogs, apply in 2-3 different spots. ​Do not bathe your dog for 48 hours before or 24 hours after application.​

​Warning:​ Never use this product on cats. Keep treated dogs away from ponds and streams, as the medication is toxic to aquatic life.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.